An estimation of the prevalence of nonmelanoma skin cancer in the U.S.

Nonmelanoma skin cancer (NMSC) is the most commonly diagnosed cancer in Australia and has a significant impact on the cost of and use of healthcare resources. Current estimates of NMSC in the USA are 3.5 million cases in 2010 compared to 1.63 million cases of all other cancers combined.  However, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Perera, Eshini, Sinclair, Rodney
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000Research 2013
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3752668/
https://www.ncbi.nlm.nih.gov/pubmed/24358841
http://dx.doi.org/10.12688/f1000research.2-107.v1
_version_ 1782281752384897024
author Perera, Eshini
Sinclair, Rodney
author_facet Perera, Eshini
Sinclair, Rodney
author_sort Perera, Eshini
collection PubMed
description Nonmelanoma skin cancer (NMSC) is the most commonly diagnosed cancer in Australia and has a significant impact on the cost of and use of healthcare resources. Current estimates of NMSC in the USA are 3.5 million cases in 2010 compared to 1.63 million cases of all other cancers combined.  However, we believe that this figure significantly underestimates the prevalence of NMSC in the USA.  We calculated that melanoma is diagnosed 5.7 times more in the USA than in Australia.  In Australia, in 2010, there were 767,000 NMSC diagnoses.  If the ratio of melanoma: NMSC is constant in both Australia and the USA, then there should be 5.7 times the number of NMSC in the USA or 4.3 million cases.  The assumptions that underlie this calculation are discussed.
format Online
Article
Text
id pubmed-3752668
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher F1000Research
record_format MEDLINE/PubMed
spelling pubmed-37526682013-12-05 An estimation of the prevalence of nonmelanoma skin cancer in the U.S. Perera, Eshini Sinclair, Rodney F1000Res Commentary Nonmelanoma skin cancer (NMSC) is the most commonly diagnosed cancer in Australia and has a significant impact on the cost of and use of healthcare resources. Current estimates of NMSC in the USA are 3.5 million cases in 2010 compared to 1.63 million cases of all other cancers combined.  However, we believe that this figure significantly underestimates the prevalence of NMSC in the USA.  We calculated that melanoma is diagnosed 5.7 times more in the USA than in Australia.  In Australia, in 2010, there were 767,000 NMSC diagnoses.  If the ratio of melanoma: NMSC is constant in both Australia and the USA, then there should be 5.7 times the number of NMSC in the USA or 4.3 million cases.  The assumptions that underlie this calculation are discussed. F1000Research 2013-04-09 /pmc/articles/PMC3752668/ /pubmed/24358841 http://dx.doi.org/10.12688/f1000research.2-107.v1 Text en Copyright: © 2013 Perera E et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/publicdomain/zero/1.0/ Data associated with the article are available under the terms of the Creative Commons Zero "No rights reserved" data waiver (CC0 1.0 Public domain dedication).
spellingShingle Commentary
Perera, Eshini
Sinclair, Rodney
An estimation of the prevalence of nonmelanoma skin cancer in the U.S.
title An estimation of the prevalence of nonmelanoma skin cancer in the U.S.
title_full An estimation of the prevalence of nonmelanoma skin cancer in the U.S.
title_fullStr An estimation of the prevalence of nonmelanoma skin cancer in the U.S.
title_full_unstemmed An estimation of the prevalence of nonmelanoma skin cancer in the U.S.
title_short An estimation of the prevalence of nonmelanoma skin cancer in the U.S.
title_sort estimation of the prevalence of nonmelanoma skin cancer in the u.s.
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3752668/
https://www.ncbi.nlm.nih.gov/pubmed/24358841
http://dx.doi.org/10.12688/f1000research.2-107.v1
work_keys_str_mv AT pereraeshini anestimationoftheprevalenceofnonmelanomaskincancerintheus
AT sinclairrodney anestimationoftheprevalenceofnonmelanomaskincancerintheus
AT pereraeshini estimationoftheprevalenceofnonmelanomaskincancerintheus
AT sinclairrodney estimationoftheprevalenceofnonmelanomaskincancerintheus

Ejemplares similares